This inventor holds 1 USPTO granted patent. Top assignees: Assistance Publique-Hopitaux De Paris, Biopredictive. Active years: 2025.
Company Filing History:
1 out of 331 
1 out of 4 Years Active: 2025
Title: Olivier Deckmyn: Innovator in SARS-CoV-2 Diagnosis
Introduction
Olivier Deckmyn is a notable inventor based in Cabriès, France. He has made significant contributions to the field of medical diagnostics, particularly in relation to the SARS-CoV-2 virus. His innovative approach has the potential to enhance the accuracy and efficiency of infection detection.
Latest Patents
Olivier Deckmyn holds a patent for a "Method of diagnosis of infection by the SARS-CoV-2 virus." This invention relates to a new non-invasive test that allows for the detection of infection by the SARS-CoV-2 virus in a patient. The method utilizes values of Apolipoprotein A1 alone or in combination with other markers, showcasing a novel approach to diagnosing this viral infection.
Career Highlights
Throughout his career, Olivier Deckmyn has worked with prominent organizations, including Biopredictive and Assistance Publique-Hôpitaux de Paris. His experience in these institutions has contributed to his expertise in medical diagnostics and innovation.
Collaborations
Olivier has collaborated with esteemed colleagues such as Thierry Poynard and Patrice Cacoub. These partnerships have likely enriched his research and development efforts in the medical field.
Conclusion
Olivier Deckmyn's work in developing a non-invasive diagnostic method for SARS-CoV-2 infection exemplifies his commitment to advancing medical technology. His contributions are significant in the ongoing fight against viral infections.